{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:46:57Z","timestamp":1789102017415,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.lungcan.2024.107829","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:21:55Z","timestamp":1716391315000},"page":"107829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer"],"prefix":"10.1016","volume":"192","author":[{"given":"Helen","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-7397","authenticated-orcid":false,"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.J.","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannel","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lungcan.2024.107829_b0005","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1470-2045(22)00269-8","article-title":"The silent malignant mesothelioma epidemic: a call to action","volume":"23","author":"van Zandwijk","year":"2022","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14737140.2020.1745067","article-title":"Asbestos-related cancers: the 'Hidden Killer' remains a global threat","volume":"20","author":"van Zandwijk","year":"2020","journal-title":"Expert Rev Anticancer Ther."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107829_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.critrevonc.2012.03.001","article-title":"The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma","volume":"84","author":"Linton","year":"2012","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201302-0257OC","article-title":"Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort","volume":"188","author":"Markowitz","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0025","first-page":"239","article-title":"The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain (1971\u20132005)","volume":"55","author":"Frost","year":"2011","journal-title":"Ann Occup Hyg."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/oem.58.3.145","article-title":"Relation between exposure to asbestos and smoking jointly and the risk of lung cancer","volume":"58","author":"Lee","year":"2001","journal-title":"Occup Environ Med."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107829_b0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/155.11.1016","article-title":"Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm","volume":"155","author":"Gustavsson","year":"2002","journal-title":"Sweden. Am J Epidemiol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/ijerph17010258","article-title":"Asbestos, Smoking and Lung Cancer: An Update","volume":"17","author":"Klebe","year":"2019","journal-title":"Int J Environ Res Public Health."},{"issue":"166","key":"10.1016\/j.lungcan.2024.107829_b0045","article-title":"Asbestos-related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation","volume":"31","author":"Hyland","year":"2022","journal-title":"Asia Pac J Clin Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5271\/sjweh.226","volume":"23","year":"1997","journal-title":"Scand J Work Environ Health."},{"issue":"1 Suppl 1","key":"10.1016\/j.lungcan.2024.107829_b0055","first-page":"15","article-title":"Helsinki Criteria update 2014: asbestos continues to be a challenge for disease prevention and attribution","volume":"40","author":"Vainio","year":"2016","journal-title":"Epidemiol Prev."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107829_b0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajim.22709","article-title":"Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update","volume":"60","author":"Baur","year":"2017","journal-title":"Am J Ind Med."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107829_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1179\/oeh.2009.15.2.202","article-title":"Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony","volume":"15","author":"Egilman","year":"2009","journal-title":"Int J Occup Environ Health."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0070","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.chemrestox.0c00286","article-title":"Asbestos and Zeolites: from A to Z via a Common Ion","volume":"34","author":"Reid","year":"2021","journal-title":"Chem Res Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.lungcan.2024.107829_b0075","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.21037\/tlcr.2020.02.01","article-title":"How asbestos and other fibers cause mesothelioma","volume":"9","author":"Gaudino","year":"2020","journal-title":"Transl Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0080","doi-asserted-by":"crossref","first-page":"e34943","DOI":"10.1371\/journal.pone.0034943","article-title":"MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107829_b0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/gcc.20880","article-title":"Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer","volume":"50","author":"Nymark","year":"2011","journal-title":"Genes Chromosomes Cancer."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/1055-9965.EPI-18-0453","article-title":"Four-miRNA Signature to Identify Asbestos-Related Lung Malignancies","volume":"28","author":"Santarelli","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"48","key":"10.1016\/j.lungcan.2024.107829_b0095","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1038\/sj.onc.1205804","article-title":"The molecular epidemiology of asbestos and tobacco in lung cancer","volume":"21","author":"Nelson","year":"2002","journal-title":"Oncogene."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2009.03.018","article-title":"p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos","volume":"67","author":"Andujar","year":"2010","journal-title":"Lung Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0105","doi-asserted-by":"crossref","first-page":"1700716","DOI":"10.1183\/13993003.00716-2017","article-title":"Association between lung cancer somatic mutations and occupational exposure in never-smokers","volume":"50","author":"Paris","year":"2017","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0110","doi-asserted-by":"crossref","first-page":"1702605","DOI":"10.1183\/13993003.02605-2017","article-title":"Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements","volume":"51","author":"Uguen","year":"2018","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa2112431","article-title":"Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer","volume":"386","author":"Li","year":"2022","journal-title":"N Engl J Med."},{"issue":"31","key":"10.1016\/j.lungcan.2024.107829_b0120","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1200\/JCO.23.01361","article-title":"Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial","volume":"41","author":"Goto","year":"2023","journal-title":"J Clin Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107829_b0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research T","year":"2011","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107829_b0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107829_b0135","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1208962","article-title":"Results of the two incidence screenings in the National Lung Screening Trial","volume":"369","author":"Aberle","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.lungcan.2024.107829_b0140","article-title":"Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis","volume":"10","author":"Field","year":"2021","journal-title":"Lancet Reg Health Eur."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/19338244.2013.863752","article-title":"Occupational asbestos exposure and lung cancer\u2013a systematic review of the literature","volume":"69","author":"Nielsen","year":"2014","journal-title":"Arch Environ Occup Health."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107829_b0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/resp.14487","article-title":"Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient","volume":"28","author":"Brims","year":"2023","journal-title":"Respirology."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107829_b0155","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1378\/chest.13-2181","article-title":"Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis","volume":"145","author":"Ollier","year":"2014","journal-title":"Chest."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107829_b0160","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"Force","year":"2021","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/ijms23031671","article-title":"Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells","volume":"23","author":"Yeo","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.lungcan.2024.107829_b0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.envres.2017.03.055","article-title":"Analysis of fibulin-3 after exposure to asbestos-like fibers","volume":"156","author":"Rapisarda","year":"2017","journal-title":"Environ Res."},{"key":"10.1016\/j.lungcan.2024.107829_b0175","doi-asserted-by":"crossref","first-page":"1725354","DOI":"10.1155\/2017\/1725354","article-title":"Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population","volume":"2017","author":"Jiang","year":"2017","journal-title":"Dis Markers."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107829_b0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1383-5718(00)00053-X","article-title":"Levels of 8-hydroxy-2'-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany","volume":"468","author":"Marczynski","year":"2000","journal-title":"Mutat Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41416-020-01176-x","article-title":"Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis","volume":"124","author":"Perea Paizal","year":"2021","journal-title":"Br J Cancer."},{"issue":"166","key":"10.1016\/j.lungcan.2024.107829_b0190","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0151-2022","article-title":"Circulating tumour cells in patients with lung cancer universally indicate poor prognosis","volume":"31","author":"Jin","year":"2022","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.lungcan.2024.107829_b0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2019.04.019","article-title":"EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer","volume":"117","author":"Lindsay","year":"2019","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.lungcan.2024.107829_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104237","article-title":"Circulating tumor cell isolation for cancer diagnosis and prognosis","volume":"83","author":"Deng","year":"2022","journal-title":"EBioMedicine."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107829_b0205","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/cancers13050970","article-title":"A Review of Circulating Tumour Cell Enrichment Technologies","volume":"13","author":"Rushton","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"12","key":"10.1016\/j.lungcan.2024.107829_b0210","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107829_b0215","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med."},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2024.107829_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-010-0115-3","article-title":"Circulating tumor cells in colorectal cancer: past, present, and future challenges","volume":"11","author":"Negin","year":"2010","journal-title":"Curr Treat Options Oncol."},{"key":"10.1016\/j.lungcan.2024.107829_b0225","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/617421","article-title":"Significance of Circulating Tumor Cells Detected by the Cell Search System in Patients with Metastatic Breast Colorectal and Prostate Cancer","volume":"2010","author":"Miller","year":"2010","journal-title":"J Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1470-2045(08)70340-1","article-title":"Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data","volume":"10","author":"Scher","year":"2009","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107829_b0235","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2353\/ajpath.2009.090078","article-title":"Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy","volume":"175","author":"Hou","year":"2009","journal-title":"Am J Pathol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0240","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/cells9040888","article-title":"Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the \u201cUniversal\u201d CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2","volume":"9","author":"Kuwata","year":"2020","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0245","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/ol.2021.12783","article-title":"Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma","volume":"22","author":"Kanayama","year":"2021","journal-title":"Oncol Lett."},{"issue":"Suppl 4","key":"10.1016\/j.lungcan.2024.107829_b0250","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1245\/s10434-013-3399-2","article-title":"Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM)","volume":"21","author":"Yoneda","year":"2014","journal-title":"Ann Surg Oncol."},{"issue":"7586","key":"10.1016\/j.lungcan.2024.107829_b0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massague","year":"2016","journal-title":"Nature."},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2024.107829_b0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jnci\/djy152","article-title":"Presence of circulating tumor cells in high-risk early breast cancer during follow-up and prognosis","volume":"111","author":"Trapp","year":"2019","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10641955.2016.1143487","article-title":"Detection of circulating trophoblast particles in maternal blood using density gradient centrifugation in preeclampsia and in normotensive pregnancies","volume":"35","author":"Kuessel","year":"2016","journal-title":"Hypertens Pregnancy."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107829_b0275","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","article-title":"Circulating epithelial cells in patients with benign colon diseases","volume":"58","author":"Pantel","year":"2012","journal-title":"Clin Chem."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107829_b0280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","article-title":"Circulating tumour cells for early detection of clinically relevant cancer","volume":"20","author":"Lawrence","year":"2023","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.lungcan.2024.107829_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4653109","article-title":"Screening circulating tumor cells as a noninvasive cancer test in 3388 individuals from high-risk groups (ICELLATE2)","volume":"2018","author":"Castro","year":"2018","journal-title":"Dis Markers."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107829_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111597","article-title":"\u201cSentinel\u201d circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease","volume":"9","author":"Ilie","year":"2014","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107829_b0295","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-2600(20)30081-3","article-title":"Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study","volume":"8","author":"Marquette","year":"2020","journal-title":"Lancet Respir Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0300","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/15384047.2016.1141839","article-title":"Identifying cancer origin using circulating tumor cells","volume":"17","author":"Lu","year":"2016","journal-title":"Cancer Biol Ther."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107829_b0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers11030380","article-title":"Phenotypic characterization of circulating lung cancer cells for clinically actionable targets","volume":"11","author":"Kulasinghe","year":"2019","journal-title":"Cancers (basel)."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0310","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12885-017-3316-3","article-title":"PD-L1 expressing circulating tumour cells in head and neck cancers","volume":"17","author":"Kulasinghe","year":"2017","journal-title":"BMC Cancer."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107829_b0315","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","article-title":"Frequent expression of PD-L1 on circulating breast cancer cells","volume":"9","author":"Mazel","year":"2015","journal-title":"Mol Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107829_b0320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/cancers10080270","article-title":"Assessment of the mutational status of NSCLC using hypermetabolic circulating tumor cells","volume":"10","author":"Turetta","year":"2018","journal-title":"Cancers (basel)."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107829_b0325","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"Hodgkinson","year":"2014","journal-title":"Nat Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-022-01553-5","article-title":"Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses","volume":"21","author":"Suvilesh","year":"2022","journal-title":"Mol Cancer."},{"issue":"23","key":"10.1016\/j.lungcan.2024.107829_b0335","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.18632\/oncotarget.2592","article-title":"Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107829_b0340","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/cancers12113394","article-title":"Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (basel)."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41698-021-00203-1","article-title":"Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors","volume":"5","author":"Oulhen","year":"2021","journal-title":"NPJ Precis Oncol."},{"issue":"16","key":"10.1016\/j.lungcan.2024.107829_b0350","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-18-3571","article-title":"Inferring the evolution and progression of small-cell lung cancer by single-cell sequencing of circulating tumor cells","volume":"25","author":"Su","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107829_b0355","doi-asserted-by":"crossref","first-page":"13630","DOI":"10.1038\/s41598-021-93053-7","article-title":"Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors","volume":"11","author":"Dietz","year":"2021","journal-title":"Sci Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107829_b0360","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jcmgh.2019.07.002","article-title":"Circulating hybrid cells join the fray of circulating cellular biomarkers","volume":"8","author":"Sutton","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T22:11:52Z","timestamp":1717539112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224003635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":72,"alternative-id":["S0169500224003635"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107829","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107829"}}